These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38669836)
121. Diagnostic challenge of an untypical cutaneous drug reaction from modafinil. Harvima RJ; Heiskanen-Kosma T; Arvonen M; Harvima IT Clin Case Rep; 2024 Sep; 12(9):e9166. PubMed ID: 39290249 [TBL] [Abstract][Full Text] [Related]
122. Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial. Trotti LM; Blake T; Hoque R; Rye DB; Sharma S; Bliwise DL CNS Drugs; 2024 Nov; 38(11):909-920. PubMed ID: 39306601 [TBL] [Abstract][Full Text] [Related]
123. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575 [TBL] [Abstract][Full Text] [Related]
125. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology; 2000 Mar; 54(5):1166-75. PubMed ID: 10720292 [TBL] [Abstract][Full Text] [Related]
126. Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study. Chin WC; Huang YS; Trevor Lam NY; Mak KY; Tang I; Wang CH; Lin C Sleep Med; 2024 Jul; 119():95-102. PubMed ID: 38669836 [TBL] [Abstract][Full Text] [Related]
127. Modafinil in the treatment of excessive daytime sleepiness. Valentino RM; Foldvary-Schaefer N Cleve Clin J Med; 2007 Aug; 74(8):561-6, 568-71. PubMed ID: 17708127 [TBL] [Abstract][Full Text] [Related]
128. [Sleep and wakefulness drugs and their indications]. Bourin M Ann Pharm Fr; 2007 Jul; 65(4):251-7. PubMed ID: 17652993 [TBL] [Abstract][Full Text] [Related]
130. Approved and investigational uses of modafinil : an evidence-based review. Kumar R Drugs; 2008; 68(13):1803-39. PubMed ID: 18729534 [TBL] [Abstract][Full Text] [Related]
131. Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. Myrick H; Malcolm R; Taylor B; LaRowe S Ann Clin Psychiatry; 2004; 16(2):101-9. PubMed ID: 15328903 [TBL] [Abstract][Full Text] [Related]
132. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Jasinski DR; Kovacević-Ristanović R Clin Neuropharmacol; 2000; 23(3):149-56. PubMed ID: 10895398 [TBL] [Abstract][Full Text] [Related]
133. Pharmacological management of narcolepsy with and without cataplexy. Kallweit U; Bassetti CL Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381 [TBL] [Abstract][Full Text] [Related]
134. Treatment of narcolepsy and other hypersomnias of central origin. Wise MS; Arand DL; Auger RR; Brooks SN; Watson NF; Sleep; 2007 Dec; 30(12):1712-27. PubMed ID: 18246981 [TBL] [Abstract][Full Text] [Related]